Copyright
©The Author(s) 2017.
World J Hepatol. Jun 28, 2017; 9(18): 823-832
Published online Jun 28, 2017. doi: 10.4254/wjh.v9.i18.823
Published online Jun 28, 2017. doi: 10.4254/wjh.v9.i18.823
Table 1 Patient demographics
Variables | No AKI (n = 58) | Any grade of AKI (n = 58) | P value |
Patient characteristics | |||
Age (yr) | 54 (18) | 56 (6) | 0.197 |
Female | 17 (29%) | 16 (28%) | 0.837 |
Weight (kg) | 75 (13) | 79 (15) | 0.163 |
Aetiology | |||
Alcohol | 13 | 14 | |
Viral hepatitis | 20 | 25 | |
NASH | 2 | 7 | |
Autoimmune | 16 | 7 | |
Hepatocellular carcinoma | 10 | 13 | |
Other | 7 | 6 | |
MELD score | 16 (7) | 16 (5.75) | 0.421 |
Hypertension | 8 (14%) | 9 (16%) | 0.733 |
Diabetes mellitus | 12 (21%) | 20 (34%) | 0.074 |
Pre-operative Haemoglobin (g/L) | 114 (20) | 107 (26) | 0.072 |
Baseline creatinine | 76 (39) | 75 (26) | 0.932 |
Table 2 Donor graft characteristics
Variables | No AKI (n = 58) | Any AKI (n = 58) | P value |
Graft characteristics | |||
Donor age (yr) | 50 (14) | 47 (15) | 0.219 |
Organ status | |||
DCD (%) | 7 (12%) | 10 (17%) | 0.454 |
Cold Ischaemic time (min) | 493 (133) | 493 (106) | 0.502 |
Table 3 Intraoperative variables
Variable | No AKI (n = 58) | Any AKI (n = 58) | P value |
Intraoperative variables | |||
Surgical technique | |||
Piggyback | 33 (57%) | 22 (38%) | 0.041 |
Intraoperative blood products | |||
RCC transfusion (units) | 1 (3) | 4 (5) | 0.001 |
FFP transfusion (units) | 0 (2) | 2 (6) | 0.001 |
Platelet transfusion (units) | 0 (1) | 0 (2) | 0.024 |
Cell salvage (mL) | 281 (550) | 764 (929) | 0.001 |
Noradrenaline infusion rate on arrival to ICU (μg/kg per minute) | 0.16 (0.10) | 0.18 (0.13) | 0.343 |
Table 4 Logistic regression analysis of variables associated with early acute kidney injury after liver transplantation
Univariate analysis | Multivariate model | |||
Variables | Odds ratio (95%CI) | P value | Odds ratio (95%CI) | P value |
Male gender | 1.088 (0.49-2.44) | 0.837 | 0.430 (0.07-2.55) | 0.352 |
Weight | 1.020 (0.99-1.05) | 0.164 | 1.026 (0.96-1.10) | 0.455 |
Age | 1.034 (0.999-1.07) | 0.058 | 1.121 (1.02-1.23) | 0.019 |
Pre-transplant | ||||
Diabetes mellitus | 2.130 (0.92-4.92) | 0.077 | 2.429 (0.48-12.41) | 0.286 |
Hypertension | 1.197 (0.43-3.36) | 0.733 | 0.593 (0.04-8.04) | 0.694 |
Serum creatinine | 1.000 (0.99-1.01) | 0.937 | 0.979 (0.96-1.002) | 0.078 |
MELD | 1.010 (0.97-1.05) | 0.639 | 0.992 (0.91-1.08) | 0.845 |
Haemoglobin | 0.985 (0.97-1.002) | 0.076 | 0.977 (0.93-1.02) | 0.311 |
Graft characteristics | ||||
DCD organ | 1.488 (0.52-4.23) | 0.455 | 2.638 (0.30-23.12) | 0.381 |
Donor age | 0.984 (0.96-1.01) | 0.218 | 0.964 (0.92-1.01) | 0.160 |
Cold ischaemic time | 1.001 (0.99-1.004) | 0.498 | 1.000 (0.99-1.01) | 0.984 |
Peak serum AST < 24 h post OLT | 1.001 (1.00-1.001) | 0.001 | 1.001 (1.00-1.001) | 0.020 |
Perioperative course | ||||
Caval replacement surgical technique | 2.160 (1.03-4.54) | 0.042 | 3.289 (0.71-15-25) | 0.128 |
Noradrenaline infusion rate on ICU arrival | 4.830 (0.19-125.48) | 0.343 | 47.468 (0.12-1836.27) | 0.204 |
RCC transfusion | 1.137 (1.03-1.26) | 0.014 | 0.917 (0.64-1.32) | 0.645 |
FFP transfusion | 1.201 (1.07-1.35) | 0.003 | 1.118 (0.84-1.48) | 0.440 |
Platelet transfusion | 1.499 (1.04-2.16) | 0.030 | 1.948 (0.871-4.36) | 0.104 |
Cell salvage volume | 1.001 (1.00-1.001) | 0.025 | 1.00 (0.999-1.002) | 0.808 |
Table 5 The effect of organ status and surgical technique on hepatic ischaemia reperfusion injury severity and the renal implications of increasing ischaemia reperfusion injury n (%)
Severity of HIRI | ||||
Mild (n = 35) | Moderate (n = 68) | Severe (n = 13) | P value | |
DCD organs | 1/35 (2.9) | 11/68 (16.2) | 5/13 (38.5) | 0.007 |
Caval replacement | 16/35 (45.7) | 36/68 (52.9) | 9/13 (69.2) | 0.348 |
Incidence of AKI | 12/35 (34.3) | 34/68 (50.0) | 12/13 (92.3) | 0.002 |
Need for CVVHF | 5/35 (14.3) | 15/68 (22.1) | 8/13 (61.5) | 0.003 |
Development of CRF | 6/30 (20.0) | 19/53 (35.8) | 5/11 (45.5) | 0.195 |
- Citation: Rahman S, Davidson BR, Mallett SV. Early acute kidney injury after liver transplantation: Predisposing factors and clinical implications. World J Hepatol 2017; 9(18): 823-832
- URL: https://www.wjgnet.com/1948-5182/full/v9/i18/823.htm
- DOI: https://dx.doi.org/10.4254/wjh.v9.i18.823